Cognex Corporation $CGNX Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC trimmed its holdings in Cognex Corporation (NASDAQ:CGNX) by 48.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 62,856 shares of the scientific and technical instruments company’s stock after selling 58,108 shares during the period. Hsbc Holdings PLC’s holdings in Cognex were worth $1,990,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Geneos Wealth Management Inc. boosted its position in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares during the last quarter. Penserra Capital Management LLC acquired a new stake in Cognex in the 2nd quarter valued at about $29,000. TD Waterhouse Canada Inc. purchased a new position in Cognex in the 2nd quarter worth approximately $29,000. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Cognex by 231.9% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,082 shares of the scientific and technical instruments company’s stock worth $34,000 after purchasing an additional 756 shares during the last quarter. Finally, Farther Finance Advisors LLC grew its position in shares of Cognex by 31.5% in the second quarter. Farther Finance Advisors LLC now owns 1,277 shares of the scientific and technical instruments company’s stock valued at $40,000 after purchasing an additional 306 shares in the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Barclays reissued an “overweight” rating and set a $56.00 price objective (up previously from $55.00) on shares of Cognex in a research note on Friday, October 31st. KeyCorp reissued an “overweight” rating and set a $50.00 price target on shares of Cognex in a research report on Friday, October 31st. Needham & Company LLC raised their price objective on shares of Cognex from $45.00 to $47.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. Truist Financial set a $45.00 target price on shares of Cognex and gave the stock a “hold” rating in a research note on Wednesday, October 8th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a report on Monday, December 1st. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $45.53.

Insiders Place Their Bets

In related news, Director Robert Willett sold 6,704 shares of the business’s stock in a transaction on Tuesday, October 21st. The stock was sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Sheila Marie Dipalma sold 2,000 shares of the firm’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $45.03, for a total value of $90,060.00. Following the transaction, the executive vice president owned 6,582 shares of the company’s stock, valued at $296,387.46. This trade represents a 23.30% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.60% of the stock is owned by corporate insiders.

Cognex Trading Down 1.2%

Shares of CGNX opened at $38.42 on Friday. The company’s 50-day moving average price is $41.94 and its 200 day moving average price is $38.83. Cognex Corporation has a 12-month low of $22.67 and a 12-month high of $49.76. The firm has a market cap of $6.44 billion, a P/E ratio of 60.03 and a beta of 1.53.

Cognex (NASDAQ:CGNX) last announced its earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.06. The company had revenue of $264.00 million during the quarter, compared to analyst estimates of $261.86 million. Cognex had a net margin of 11.33% and a return on equity of 8.26%. Cognex’s revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Equities research analysts forecast that Cognex Corporation will post 0.61 earnings per share for the current year.

Cognex Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Thursday, November 13th were issued a $0.085 dividend. This is a boost from Cognex’s previous quarterly dividend of $0.08. The ex-dividend date was Thursday, November 13th. This represents a $0.34 annualized dividend and a yield of 0.9%. Cognex’s payout ratio is 53.13%.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.